ly to have children with asthma. During the first six months of life, half of the infants will receive a once-daily dose of active Lactobacillus GG and half will receive a placebo. The babies will be followed for three years, with six follow-up visits at UCSF Children's Hospital or an outpatient center starting at one month old. Researchers will analyze the data from the visits to see if the active supplements prevented or delayed the appearance of the early signs of asthma. Cabana said a similar study conducted in Finland found that administration of Lactobacillus to infants delayed or prevented the onset of eczema.
According to the American Lung Association, an estimated 4 million children under 18 years old have had an asthma attack in the past 12 months, and many others have hidden or undiagnosed asthma. Other study co-investigators include Joan Hilton, ScD; Cewin Chao, MS, RD, MBA; Homer Boushey, MD; Lawrence Fong, MD, PhD; and Aaron Brandon Caughey, MD, MPP, MPH, all of UCSF.
Source: Eurekalert
'"/>Page: 1 2 Related medicine news :1.
Ramdoss Announces Introduction of RCH-II2.
Earlier Introduction of Solid Foods in Infants Could Prevent Wheat Allergy3.
IMA Oppose Introduction of Polio Injections4.
Anti-Microbial Coating For Use Over Biomedical Devices Developed5.
Misuse Of Anti-Microbial Drugs Have Given Rise To Multidrug-resistant TB Strains6.
Life Saving Cancer Drugs – From Chicken! Possible Says Dolly’ Creatos7.
Possible benefits of Hormone Replacement Therapy8.
Low Protein Levels A Possible Indicator For A Miscarriage9.
Cure For Persistent Oral Fungal Problem May Be Possible10.
Transfer Of Rabies Virus Possible From Organ Donor To Recipient
11.
Possible location of lung cancer genes found